| |
Directors
Founders of the
company have worked in the area of oral administration of proteins and vaccines
for many years, Glen Travers in the biotechnology industry including project management
and corporate development, and Dr Roger New, working as a scientist both in academia
and in industry. Salient achievements of both individuals are
listed below.
The company is managed by an International Board of Directors and controlled from Jersey
 |
Dr Roger New
- Thirty years experience of Research
and Development in field of drug delivery
- World-recognised expert in liposomes: author
of seminal reference book “Liposomes - A Practical Approach” published
by OUP
- First to demonstrate efficacy of liposomal
amphotericin. Coordinated first Phase I/II trials of liposomal
doxorubicin
- Devised three new systems for oral delivery
of insulin, giving first positive human results ever observed
in Type I diabetics
- Honorary professor at several foreign
academic institutions. Consultant advisor to IRCD. Member
of UK Govt Expert Mission on Biotechnology to China and Brazil
- Patent applications filed and granted
in areas of pharmaceutics, diagnostics and microbiology
- Inventor of Patents
|
 |
Glen Travers
Achievements as co-founder and chief executive
in biopharmaceutical arena:
- Developed and launched ‘89 first
helicobacter diagnostic - CLOTEST
- Licensed to Upjohn for USA- Royalties
received for 10 years
- Developed and launched first Hp point
of care diagnostic - HELISAL
- Launched with Astra in UK, Boehringer
Mannheim ROW, Becton Dickinson USA
- Developed and launched with Ciba
animal care antibacterial DETACH in Australia
- Developed and launched first oral mucosal
vaccine – BRONCOSTAT, sold to RPR 1990
- Developed first point-of-care osteoporosis
diagnostic ‘98 - OSTEOSAL
- Developed first point-of-care HBA1c
diagnostic ‘98 – GLYCOSAL
- Founded and built biopharmaceutical
company to peak $1.2bn value ($0.5bn on departure)
- Listed company in UK, Australia, Nasdaq,
and developed £7m turnover for UK pharmaceutical distribution
- Registered new products with FDA,MCA
- Developed collaborations with 12 Universities
including Centre for Vaccine Development at Cambridge University
- European Healthcare Entrepreneur of
the Year 1996 sponsored by Ernst & Young and Atlas Ventures
|
|
